Replies to post #3269 on CV Sciences Inc (CVSI)

[todboyd]

nah, earlier

[Det_Robert_Thorne]

Why? CANV has a lot of issues

Did you see the S-8 filing from a few days ago? In that filing CANV states that with the termination of the agreement with HempMeds, management expects to see revenues through their main channel decline:

Until August 11, 2014, approximately 90% of our sales were to HempMeds PX, LLC, which is a wholly-owned subsidiary of MJNA. On August 11, 2014, we terminated the Non-Exclusive License and Distribution Agreement with HempMeds PX, LLC (the “HempMeds Agreement”). As a result, we expect sales to HempMeds, PX, LLC to decline and perhaps discontinue entirely. Although we have been successful in securing additional customers and receiving revenue from other customers since the termination of the HempMeds Agreement, if those customers were to fail, and if we are not able to further expand our customer base, our prospects and operations would materially and negatively be affected.

http://www.sec.gov/Archives/edgar/data/1510964/000101968714003799/cannavest_s8.htm
In addition, the form also discloses that the CEO will be receiving 500K shares as compensation, plus options for another 1.1M shares were awarded to the CEO and CFO.

This means more dilution.